| Germline mutations in ETV6 are associated with thrombocytopenia, red cell macrocytosis and predisposition to lymphoblastic leukemia L Noetzli, RW Lo, AB Lee-Sherick, M Callaghan, P Noris, A Savoia, ... Nature genetics 47 (5), 535-538, 2015 | 340 | 2015 |
| STAT3-mediated autophagy dependence identifies subtypes of breast cancer where autophagy inhibition can be efficacious P Maycotte, CM Gearheart, R Barnard, S Aryal, JM Mulcahy Levy, ... Cancer research 74 (9), 2579-2590, 2014 | 196 | 2014 |
| Surveillance recommendations for children with overgrowth syndromes and predisposition to Wilms tumors and hepatoblastoma JM Kalish, L Doros, LJ Helman, RC Hennekam, RP Kuiper, SM Maas, ... Clinical Cancer Research 23 (13), e115-e122, 2017 | 184 | 2017 |
| Irradiation selects for p53-deficient hematopoietic progenitors A Marusyk, CC Porter, V Zaberezhnyy, J DeGregori PLoS biology 8 (3), e1000324, 2010 | 161 | 2010 |
| Tankyrase and the canonical Wnt pathway protect lung cancer cells from EGFR inhibition M Casás-Selves, J Kim, Z Zhang, BA Helfrich, D Gao, CC Porter, ... Cancer research 72 (16), 4154-4164, 2012 | 151 | 2012 |
| ClinGen Myeloid Malignancy Variant Curation Expert Panel recommendations for germline RUNX1 variants X Luo, S Feurstein, S Mohan, CC Porter, SA Jackson, S Keel, M Chicka, ... Blood advances 3 (20), 2962-2979, 2019 | 132 | 2019 |
| Cancer screening recommendations and clinical management of inherited gastrointestinal cancer syndromes in childhood MI Achatz, CC Porter, L Brugières, H Druker, T Frebourg, WD Foulkes, ... Clinical Cancer Research 23 (13), e107-e114, 2017 | 128 | 2017 |
| Inhibition of Wee1 Sensitizes Cancer Cells to Antimetabolite Chemotherapeutics In Vitro and In Vivo, Independent of p53 Functionality AA Van Linden, D Baturin, JB Ford, SP Fosmire, L Gardner, C Korch, ... Molecular cancer therapeutics 12 (12), 2675-2684, 2013 | 121 | 2013 |
| Recommendations for surveillance for children with leukemia-predisposing conditions CC Porter, TE Druley, A Erez, RP Kuiper, K Onel, JD Schiffman, ... Clinical Cancer Research 23 (11), e14-e22, 2017 | 117 | 2017 |
| Recommendations for childhood cancer screening and surveillance in DNA repair disorders MF Walsh, VY Chang, WK Kohlmann, HS Scott, C Cunniff, F Bourdeaut, ... Clinical Cancer Research 23 (11), e23-e31, 2017 | 115 | 2017 |
| MAPK signaling cascades mediate distinct glucocorticoid resistance mechanisms in pediatric leukemia CL Jones, CM Gearheart, S Fosmire, C Delgado-Martin, NA Evensen, ... Blood, The Journal of the American Society of Hematology 126 (19), 2202-2212, 2015 | 100 | 2015 |
| Mass cytometry reveals global immune remodeling with multi-lineage hypersensitivity to type I interferon in Down syndrome KA Waugh, P Araya, A Pandey, KR Jordan, KP Smith, RE Granrath, ... Cell reports 29 (7), 1893-1908. e4, 2019 | 98 | 2019 |
| Solution characterization of the extracellular region of CD147 and its interaction with its enzyme ligand cyclophilin A J Schlegel, JS Redzic, CC Porter, V Yurchenko, M Bukrinsky, ... Journal of molecular biology 391 (3), 518-535, 2009 | 97 | 2009 |
| Integrated genomic analyses identify WEE1 as a critical mediator of cell fate and a novel therapeutic target in acute myeloid leukemia CC Porter, J Kim, S Fosmire, CM Gearheart, A van Linden, D Baturin, ... Leukemia 26 (6), 1266-1276, 2012 | 88 | 2012 |
| ATM and MET kinases are synthetic lethal with nongenotoxic activation of p53 KD Sullivan, N Padilla-Just, RE Henry, CC Porter, J Kim, JJ Tentler, ... Nature chemical biology 8 (7), 646-654, 2012 | 82 | 2012 |
| A small-molecule inhibitor of WEE1, AZD1775, synergizes with olaparib by impairing homologous recombination and enhancing DNA damage and apoptosis in acute leukemia TB Garcia, JC Snedeker, D Baturin, L Gardner, SP Fosmire, C Zhou, ... Molecular cancer therapeutics 16 (10), 2058-2068, 2017 | 75 | 2017 |
| Immune responses to influenza immunization in children receiving maintenance chemotherapy for acute lymphoblastic leukemia CC Porter, KM Edwards, Y Zhu, H Frangoul Pediatric blood & cancer 42 (1), 36-40, 2004 | 75 | 2004 |
| Impaired DNA replication within progenitor cell pools promotes leukemogenesis G Bilousova, A Marusyk, CC Porter, RD Cardiff, J DeGregori PLoS Biology 3 (12), e401, 2005 | 65 | 2005 |
| Germ line mutations associated with leukemias CC Porter Hematology 2014, the American Society of Hematology Education Program Book …, 2016 | 63 | 2016 |
| ETV6-related thrombocytopenia and leukemia predisposition J Di Paola, CC Porter Blood, The Journal of the American Society of Hematology 134 (8), 663-667, 2019 | 57 | 2019 |
James DeGregoriProfessor of Biochemistry and Molecular Genetics, University of Colorado SOM在 ucdenver.edu 的电子邮件经过验证
